29.500
+0,00%
2026-10-19
Fundamental Analysis
37 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -1.0% | -4.1% | 0 / 3 | +18.3% | -3.95 pp | -5.99 pp | +22.1% | 0.01 | 11.53 | 226 | +18,3% | 69,8 | −1,0% | 11.53 | 13.36 | −13,7% |
| Pts | 0 | 0 | 0 | 8 | 0 | 0 | 12 | 12 | 8 | |||||||
Valuation annotation:Price: 29.500 (close price on 2026-10-19)EPS (TTM): 2.560
Financial charts
1.Revenue & growth
VND bn204Q2/26
1.Revenue & growth
VND bn204Q2/26
2.Profit & growth
VND bn69,5Q2/26
3.Profit mix (Penman)
VND bn284Q2/26
4.Margins & cost structure
%59.1%Q2/26
5.Returns & cash cycle
% · days24.9%Q2/26
6.Earnings quality & cash
VND bn269Q2/26
7.Asset structure
VND bn1.301Q2/26
8.Funding & debt health
VND bn · times1.301Q2/26
9.Revenue backlog
VND bn6,56Q2/26
10.Valuation
times · %11,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %695Q2/26
Adjusted EPS growth, latest quarter
-1.4%
Average adjusted EPS growth, 3 quarters
-4.3%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26